EKZ-102, an experimental oral therapy for amyotrophic lateral sclerosis (ALS), is on track to enter early clinical testing in ...
I was reluctant to take medication. But with nothing to lose, I gave it a try, and my quality of life improved immeasurably.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback